ImmuCell Corporation

Healthcare

NASDAQ:ICCC · NASDAQ Capital Market

Market Cap $85.85M Beta 0.56 P/E (TTM) -158.7

$9.49 +1.97%

+$0.19 today

52W Low $4.52High $10.75

Vol 0.03M · Avg 0.03M

EPS (TTM) -$0.06Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+42.71%

Period High

$10.63

Period Low

$4.56

Latest

$9.49

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Century Therapeutics, Inc.

NASDAQ:IPSC

$196.58M

Equillium, Inc.

NASDAQ:EQ

$107.81M

Fortress Biotech, Inc.

NASDAQ:FBIO

$100.49M

OS Therapies Incorporated

AMEX:OSTX

$81.06M

Cue Biopharma, Inc.

NASDAQ:CUE

$70.99M

NRx Pharmaceuticals, Inc.

NASDAQ:NRXP

$69.75M

Outlook Therapeutics, Inc.

NASDAQ:OTLK

$63.36M

Coeptis Therapeutics, Inc.

NASDAQ:COEP

$55.98M

Genenta Science S.p.A.

GNTA

$32.55M

Senti Biosciences, Inc.

SNTI

$24.58M

What is the latest ICCC filing?

The latest filing shown is 8-K dated Jun 17, 2026.

How many recent filings does ICCC have?

Intrinsic Alpha currently shows 20 recent filings for ICCC.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.